Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1031 | 916 | 1031 | 917 | 1215 | 1895 |
Fund Return | 3.12% | -8.36% | 3.12% | -2.86% | 3.98% | 6.6% |
Place in category | 74 | 65 | 74 | 110 | 108 | 72 |
% in Category | 34 | 42 | 34 | 55 | 66 | 57 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 619.45B | 25.00 | 8.93 | 13.09 | ||
Fidelity Contrafund | 128.94B | 35.97 | 10.77 | 15.29 | ||
Fidelity Contrafund K | 128.94B | 36.05 | 10.85 | 15.38 | ||
Fidelity Total Market Index Instl b | 104.68B | 23.88 | 7.94 | 12.50 | ||
Fidelity Blue Chip Growth | 67.04B | 39.70 | 10.19 | 18.10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 34.29B | -1.53 | 0.93 | 7.31 | ||
Fidelity Select Health Care | 10.35B | 4.93 | -1.61 | 8.22 | ||
T. Rowe Price Health Sciences | 7.73B | 1.82 | -2.69 | 8.69 | ||
Fidelity Advisor Health Care T | 6.23B | 3.66 | -2.37 | 7.13 | ||
Fidelity Advisor Health Care A | 6.23B | 3.90 | -2.12 | 7.40 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Boston Scientific | US1011371077 | 10.01 | 101.70 | +0.06% | |
UnitedHealth | US91324P1021 | 8.41 | 532.83 | +0.58% | |
Eli Lilly | US5324571083 | 5.61 | 783.49 | +2.20% | |
Danaher | US2358511028 | 5.55 | 246.31 | +0.26% | |
Penumbra Inc | US70975L1070 | 4.33 | 273.67 | -0.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Strong Sell |
Technical Indicators | BUY | Strong Sell | Strong Sell |
Summary | Neutral | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review